Scholarly Index
John F. Marshall
AstraZeneca (France); 26,016 total citations; 423 total publications; best world rank #81
AstraZeneca (France)
26,016Total citations
423Total publications
92H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cell Adhesion Molecules Research | Lifetime | 132 | FR 3 | 99.44 |
| Neurotransmitter Receptor Influence on Behavior | Lifetime | 81 | FR 4 | 99.51 |
| Neuroscience and Neuropharmacology Research | Lifetime | 461 | FR 17 | 99.38 |
| Receptor Mechanisms and Signaling | Lifetime | 530 | FR 25 | 98.66 |
| Cancer Cells and Metastasis | Lifetime | 422 | FR 11 | 98.16 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 317 | FR 22 | 98.59 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 684 | FR 37 | 97.88 |
| Protease and Inhibitor Mechanisms | Lifetime | 549 | FR 17 | 96.74 |
| TGF-β signaling in diseases | Lifetime | 986 | FR 22 | 89.23 |
| Spatial Neglect and Hemispheric Dysfunction | Lifetime | 491 | FR 37 | 88.96 |
| Cell Adhesion Molecules Research | 2021-2025 | 220 | FR 6 | 85.94 |